Skip to main content
Erschienen in: Rheumatology International 9/2011

01.09.2011 | Original Article

Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus

verfasst von: Mojtaba Habibagahi, Zahra Habibagahi, Mansooreh Jaberipour, Amir Aghdashi

Erschienen in: Rheumatology International | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Regulatory T cells (Tregs) are supposed to stop immune responses in the course of immune activation. However, chronic activation of immune system in systemic lupus erythematosus (SLE) and many other autoreactive disorders are evidence of malfunction of this system. Therefore, it is plausible to quantify presence of these cells in different diseases. Forty-one patients with diagnosis of SLE were enrolled in this study. Patients were divided into two groups of patients with active and inactive disease based on the disease activity score. Flow cytometry analysis was used to determine the frequency of regulatory T cells in peripheral blood according to high expression of CD25 and intracellular Forkhead/winged-helix (Foxp3). Further 30 healthy individuals considered as control group. Significantly less CD4+CD25hi regulatory T cells were detected in active patients (P < 0.001) compared to healthy individuals. The percentage of CD4+CD25hi cells were inversely correlated with the SLEDAI disease score in patients with active disease (r = −0.837, P < 0.0001). Patients with active disease had lower frequencies of CD4+Foxp3+ cells. However, increased frequencies of CD4+Foxp3+ T cells were observed in peripheral blood of patients with inactive disease compared with active patients or healthy individuals (P < 0.010). Moreover, a significant difference between the proportion of CD4+CD25-Foxp3+ population in healthy controls and patients with active disease was shown (P < 0.0005). Presence of lower frequencies of Tregs in patients with SLE could be evaluated as an immune turbulence and could be employed as a target for immunotherapeutic manipulation. However, controversies need to be resolved.
Literatur
1.
Zurück zum Zitat Tan EM (1997) Autoantibodies and autoimmunity: a three-decade perspective. A tribute to Henry G. Kunkel. Ann NY Acad Sci 815:1–14PubMedCrossRef Tan EM (1997) Autoantibodies and autoimmunity: a three-decade perspective. A tribute to Henry G. Kunkel. Ann NY Acad Sci 815:1–14PubMedCrossRef
2.
Zurück zum Zitat Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A (2006) New insight into immunosuppression and treatment of autoimmune diseases. Clin Exp Rheumatol 24:S67–S71PubMed Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A (2006) New insight into immunosuppression and treatment of autoimmune diseases. Clin Exp Rheumatol 24:S67–S71PubMed
3.
Zurück zum Zitat Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193:1303–1310PubMedCrossRef Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193:1303–1310PubMedCrossRef
4.
Zurück zum Zitat Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167:1245–1253PubMed Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167:1245–1253PubMed
5.
Zurück zum Zitat Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061PubMedCrossRef Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061PubMedCrossRef
6.
Zurück zum Zitat Hsu WT, Suen JL, Chiang BL (2006) The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol 145:513–519PubMedCrossRef Hsu WT, Suen JL, Chiang BL (2006) The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol 145:513–519PubMedCrossRef
7.
Zurück zum Zitat Crispin JC, Martinez A, Alcocer-Varela J (2003) Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21:273–276PubMedCrossRef Crispin JC, Martinez A, Alcocer-Varela J (2003) Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21:273–276PubMedCrossRef
8.
Zurück zum Zitat Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL (2006) Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117:280–286PubMedCrossRef Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL (2006) Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117:280–286PubMedCrossRef
9.
Zurück zum Zitat Liu MF, Wang CR, Fung LL, Wu CR (2004) Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59:198–202PubMedCrossRef Liu MF, Wang CR, Fung LL, Wu CR (2004) Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59:198–202PubMedCrossRef
10.
Zurück zum Zitat Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debre P, Piette JC, Gorochov G (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175:8392–8400PubMed Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debre P, Piette JC, Gorochov G (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175:8392–8400PubMed
11.
Zurück zum Zitat Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C (2003) Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215–223PubMedCrossRef Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C (2003) Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215–223PubMedCrossRef
12.
Zurück zum Zitat Cepika AM, Marinic I, Morovic-Vergles J, Soldo-Juresa D, Gagro A (2007) Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 16:374–377PubMedCrossRef Cepika AM, Marinic I, Morovic-Vergles J, Soldo-Juresa D, Gagro A (2007) Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 16:374–377PubMedCrossRef
13.
Zurück zum Zitat Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN (2007) Regulatory T cells and human disease. Clin Dev Immunol 2007:89195PubMedCrossRef Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN (2007) Regulatory T cells and human disease. Clin Dev Immunol 2007:89195PubMedCrossRef
14.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725 Hochberg MC (1997) Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
15.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef
16.
Zurück zum Zitat Yan B, Liu Y (2009) The nature of increased circulating CD4CD25Foxp3 T cells in patients with systemic lupus erythematosus: a novel hypothesis. Open Rheumatol J 3:22–24PubMedCrossRef Yan B, Liu Y (2009) The nature of increased circulating CD4CD25Foxp3 T cells in patients with systemic lupus erythematosus: a novel hypothesis. Open Rheumatol J 3:22–24PubMedCrossRef
17.
Zurück zum Zitat Levings MK, Sangregorio R, Roncarolo MG (2001) Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295–1302PubMedCrossRef Levings MK, Sangregorio R, Roncarolo MG (2001) Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295–1302PubMedCrossRef
18.
Zurück zum Zitat Esensten JH, Wofsy D, Bluestone JA (2009) Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 5:560–565PubMedCrossRef Esensten JH, Wofsy D, Bluestone JA (2009) Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 5:560–565PubMedCrossRef
19.
Zurück zum Zitat Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St GB, Clayberger C, Soper DM, Ziegler SF, Bluestone JA (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203:1701–1711PubMedCrossRef Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St GB, Clayberger C, Soper DM, Ziegler SF, Bluestone JA (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203:1701–1711PubMedCrossRef
20.
Zurück zum Zitat Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA (2009) Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58:652–662PubMedCrossRef Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA (2009) Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58:652–662PubMedCrossRef
21.
Zurück zum Zitat Torchia D, Caproni M, Volpi W, Fabbri P (2009) Naturally occurring regulatory T cells in mucous membrane pemphigoid lesions. Acta Dermatovenerol Alp Panonica Adriat 18:3–6PubMed Torchia D, Caproni M, Volpi W, Fabbri P (2009) Naturally occurring regulatory T cells in mucous membrane pemphigoid lesions. Acta Dermatovenerol Alp Panonica Adriat 18:3–6PubMed
22.
Zurück zum Zitat Valencia X, Yarboro C, Illei G, Lipsky PE (2007) Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178:2579–2588PubMed Valencia X, Yarboro C, Illei G, Lipsky PE (2007) Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178:2579–2588PubMed
23.
Zurück zum Zitat Su MA, Stenerson M, Liu W, Putnam A, Conte F, Bluestone JA, Anderson MS (2009) The role of X-linked FOXP3 in the autoimmune susceptibility of Turner Syndrome patients. Clin Immunol 131:139–144PubMedCrossRef Su MA, Stenerson M, Liu W, Putnam A, Conte F, Bluestone JA, Anderson MS (2009) The role of X-linked FOXP3 in the autoimmune susceptibility of Turner Syndrome patients. Clin Immunol 131:139–144PubMedCrossRef
24.
Zurück zum Zitat Kuhn A, Beissert S, Krammer PH (2009) CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res 301:71–81PubMedCrossRef Kuhn A, Beissert S, Krammer PH (2009) CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res 301:71–81PubMedCrossRef
25.
Zurück zum Zitat Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E (2007) Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 16:489–496PubMedCrossRef Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E (2007) Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 16:489–496PubMedCrossRef
26.
Zurück zum Zitat Fathy A, Mohamed RW, Tawfik GA, Omar AS (2005) Diminished CD4+CD25+ T-lymphocytes in peripheral blood of patients with systemic lupus erythematosus. Egypt J Immunol 12:25–31PubMed Fathy A, Mohamed RW, Tawfik GA, Omar AS (2005) Diminished CD4+CD25+ T-lymphocytes in peripheral blood of patients with systemic lupus erythematosus. Egypt J Immunol 12:25–31PubMed
27.
Zurück zum Zitat Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN (2007) Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 601:113–119PubMedCrossRef Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN (2007) Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 601:113–119PubMedCrossRef
28.
Zurück zum Zitat Vargas-Rojas MI, Crispin JC, Richaud-Patin Y, cocer-Varela J (2008) Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17:289–294PubMedCrossRef Vargas-Rojas MI, Crispin JC, Richaud-Patin Y, cocer-Varela J (2008) Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17:289–294PubMedCrossRef
29.
Zurück zum Zitat Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C (2008) Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 20:861–868PubMedCrossRef Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C (2008) Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 20:861–868PubMedCrossRef
30.
Zurück zum Zitat Azab NA, Bassyouni IH, Emad Y, bd El-Wahab GA, Hamdy G, Mashahit MA (2008) CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 127:151–157PubMedCrossRef Azab NA, Bassyouni IH, Emad Y, bd El-Wahab GA, Hamdy G, Mashahit MA (2008) CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 127:151–157PubMedCrossRef
31.
Zurück zum Zitat Suarez A, Lopez P, Gomez J, Gutierrez C (2006) Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 65:1512–1517PubMedCrossRef Suarez A, Lopez P, Gomez J, Gutierrez C (2006) Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 65:1512–1517PubMedCrossRef
32.
Zurück zum Zitat Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN (2007) Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 123:66–73PubMedCrossRef Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN (2007) Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 123:66–73PubMedCrossRef
33.
Zurück zum Zitat Barreto M, Ferreira RC, Lourenco L, Moraes-Fontes MF, Santos E, Alves M, Carvalho C, Martins B, Andreia R, Viana JF, Vasconcelos C, Mota-Vieira L, Ferreira C, Demengeot J, Vicente AM (2009) Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol 10:5 Barreto M, Ferreira RC, Lourenco L, Moraes-Fontes MF, Santos E, Alves M, Carvalho C, Martins B, Andreia R, Viana JF, Vasconcelos C, Mota-Vieira L, Ferreira C, Demengeot J, Vicente AM (2009) Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol 10:5
34.
Zurück zum Zitat Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH (2007) The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37:987–996PubMedCrossRef Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH (2007) The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37:987–996PubMedCrossRef
35.
Zurück zum Zitat Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, Yoo WH (2008) Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 47:789–794CrossRef Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, Yoo WH (2008) Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 47:789–794CrossRef
36.
Zurück zum Zitat Barath S, Soltesz P, Kiss E, Aleksza M, Zeher M, Szegedi G, Sipka S (2007) The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity 40:521–528PubMedCrossRef Barath S, Soltesz P, Kiss E, Aleksza M, Zeher M, Szegedi G, Sipka S (2007) The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity 40:521–528PubMedCrossRef
37.
Zurück zum Zitat Wu HY, Center EM, Tsokos GC, Weiner HL (2009) Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells. Lupus 18:586–596PubMedCrossRef Wu HY, Center EM, Tsokos GC, Weiner HL (2009) Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells. Lupus 18:586–596PubMedCrossRef
38.
Zurück zum Zitat Zhang B, Zhang X, Tang F, Zhu L, Liu Y (2008) Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol 153:182–187PubMedCrossRef Zhang B, Zhang X, Tang F, Zhu L, Liu Y (2008) Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol 153:182–187PubMedCrossRef
39.
Zurück zum Zitat Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329–341PubMedCrossRef Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329–341PubMedCrossRef
40.
Zurück zum Zitat Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, Ling KL, Pratap S, Toms C, Fox BC, Cerundolo V, Powrie F, Banham AH (2005) Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35:1681–1691PubMedCrossRef Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, Ling KL, Pratap S, Toms C, Fox BC, Cerundolo V, Powrie F, Banham AH (2005) Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35:1681–1691PubMedCrossRef
41.
Zurück zum Zitat Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C (2009) Phenotypic and functional analysis of CD4+. J Immunol 182:1689–1695PubMed Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C (2009) Phenotypic and functional analysis of CD4+. J Immunol 182:1689–1695PubMed
42.
Zurück zum Zitat Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE (2008) Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 67:1037–1040PubMedCrossRef Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE (2008) Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 67:1037–1040PubMedCrossRef
43.
Zurück zum Zitat Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C (2007) Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus (SLE): a comparative phenotypic analysis. Ann Rheum Dis 67:664–671PubMedCrossRef Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C (2007) Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus (SLE): a comparative phenotypic analysis. Ann Rheum Dis 67:664–671PubMedCrossRef
44.
Zurück zum Zitat Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J (2005) Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 102:4091–4096PubMedCrossRef Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J (2005) Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 102:4091–4096PubMedCrossRef
Metadaten
Titel
Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus
verfasst von
Mojtaba Habibagahi
Zahra Habibagahi
Mansooreh Jaberipour
Amir Aghdashi
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 9/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1427-0

Weitere Artikel der Ausgabe 9/2011

Rheumatology International 9/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.